GBCI:NYSEGlacier Bancorp, Inc. Analysis
Data as of 2026-04-05 - not real-time
$45.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Glacier Bancorp (GBCI) is trading around $45.5, modestly above its 20‑day SMA (44.06) but below the 50‑day SMA (47.34), placing it near the upper end of its recent support band ($41.87) and just below the identified resistance ($45.87). The RSI sits at 52, indicating a neutral momentum stance, while the MACD histogram is positive, hinting at a slight bullish tilt. The DCF‑derived fair value of roughly $60.9 suggests an upside potential of over 20%, and the stock offers a solid 2.9% dividend yield backed by 49 consecutive quarterly payments.
Fundamentally, GBCI delivered 24.5% revenue growth YoY, with robust operating (34.8%) and profit margins (25%). A strong cash position of $1.24 B against $2.84 B of debt, coupled with a consistent dividend payout (83% of earnings) and a consensus “Buy” from six analysts, underscores its resilience despite a neutral technical outlook.
Fundamentally, GBCI delivered 24.5% revenue growth YoY, with robust operating (34.8%) and profit margins (25%). A strong cash position of $1.24 B against $2.84 B of debt, coupled with a consistent dividend payout (83% of earnings) and a consensus “Buy” from six analysts, underscores its resilience despite a neutral technical outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical resistance with bullish MACD histogram
- Dividend yield of 2.9% and recent dividend increase
- Neutral RSI indicating room for short‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicating ~21% upside
- Strong revenue growth and healthy operating margins
- Analyst consensus of “Buy” and favorable target prices around $55
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend backed by solid cash flow
- Banking sector exposure to credit risk and regulatory changes
- High payout ratio (≈83%) may limit future dividend growth
Key Metrics & Analysis
Financial Health
Revenue Growth24.50%
Profit Margin25.09%
P/E Ratio22.9
ROE6.43%
ROA0.80%
P/B Ratio1.4
Op. Cash Flow$374.4M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI52.7
Support$41.87
Resistance$45.87
MA 20$44.06
MA 50$47.34
MA 200$45.81
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$60.90
Target Price$55.33
Upside/Downside21.61%
GradeUndervalued
TypeBlend
Dividend Yield2.90%
Risk Assessment
Beta1.06
Volatility33.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.